Modulation of taurine levels in the rat liver alters methylene dianiline hepatotoxicity

Toxicology

Volumn 122, Issue 3, 1997, Pages 193-204

  Seabra, Vitor ^a,b   Timbrell, John A ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

4,4' Diaminodiphenylmethane; Bile duct toxicant; Hepatotoxicity; Protection; Taurine

Indexed keywords

4,4' METHYLENEDIANILINE; BETA ALANINE; GLUTATHIONE; GUANIDINOETHANESULFONIC ACID; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT; CONTROLLED STUDY; DOSE RESPONSE; HISTOPATHOLOGY; LIVER TOXICITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANILINE COMPOUNDS; ANIMALS; BETA-ALANINE; BILE DUCTS; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; TAURINE; TRANSAMINASES;

ANIMALIA;

EID: 0030880509     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(97)00103-0     Document Type: Article

References (47)

1. Bailie, M.B., Mullaney, T.P., Roth, R.A., 1993. Characterization of acute 4,4′-methylene dianiline hepatotoxicity in the rat. Environ. Health Perspect. 101, 130-133.
2. Dahm, L.J., Hewett, J.A., Roth, R.A., 1988. Bile and bile salts potentiate superoxide anion release from activated, rat peritoneal neutrophils. Toxicol. Appl. Pharmacol. 95, 82-92.
3. DeMaster, E.G., Redfern, B., 1987. High performance liquid chromatography of hepatic thiols with electrochemical detection. In: Jacoby, W.B., Griffith, O.W. (Eds.), Methods in Enzymology. Academic Press, New York, pp. 110-114.
4. Dorvil, N.P., Yousef, I., Tuchweber, B., Roy, C.C., 1983. Taurine prevents cholestasis induced by lithocholic acid sulphate in guinea pigs. Am. J. Clin. Nutr. 37, 221-232.
5. Ellman, G.L., 1959. Tissue sulfyhdryl groups. Arch. Biochem. Biophys. 82, 70-77.
6. Fukushima, S., Shibata, M., Hibino, T., Yoshimura, T., Hirose, M., Ito, N., 1979. Intrahepatic bile duct proliferation induced by 4,4′-diaminodiphenylmethane in rats. Toxicol. Appl. Pharmacol. 48, 145-155.
7. Gad, S.C., Weil, C.S., 1989. Statistics for toxicologists. In: Wallace Hayes, A. (Ed.), Principles and Methods of Toxicology. Raven Press, New York, pp. 435-483.
8. Gohike, R., Schmidt, P., 1974. 4,4′-diaminodiphenylmethane: Histological, enzymehistochemical and autoradiographic investigations in acute and subacute experiments in rats with and without additional heat stress. Int. Arch. Arbeitsmed. 32, 217-231.
9. Grisham, M.B., Jefferson, M.M., Melton, D.F., Thomas, E.L., 1984. Chlorinaton of endogenous amines by isolated neutrophils. J. Biol. Chem. 259, 10404-10413.
10. Hardison, W.G., 1978. Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine. Gastroenterology 75, 71-75.
11. Hardison, W.G., Proffitt, J.H., 1977. Influence of hepatic taurine concentration on bile acid conjugation with taurine. Am. J. Physiol. 232, E75-E79.
12. Huxtable, R.J., Laird II, H.E., Lippincott, S.E., 1979. The transport of taurine in the heart and the rapid depletion of tissue taurine content by guanidinoethyl sulphonate. J. Pharmacol. Exp. Ther. 211, 465-471.
13. Huxtable, R.J., 1992. Physiological actions of taurine. Physiol. Rev. 72, 101-163.
14. Ide, T., Murata, M., 1994. Reduction by guanidinoethane sulphonate of the activities of enzymes involved in taurine synthesis in rat liver. Biosci. Biotech. Biochem. 58, 1584-1588.
15. Kanz, M.F., Kaphalia, L., Kaphalia, B.S., Romagnoli, E., Ansari, G.A.S., 1992. Methylene dianiline: Acute toxicity and effects on biliary function. Toxicol. Appl. Pharmacol. 117, 88-97.
16. Kanz, M.F., Wang, A., Campbell, G.A., 1995. Infusion of bile from methylene dianiline-treated rats into the common bile duct injures biliary epithelial cells of recipient rats. Toxicol. Lett. 78, 165-171.
17. Kanz, M.F., Kaphalia, L., 1995. Low dose methylene dianiline selectively injures biliary epithelial cells (BEC). Toxicologist 15 (316) (Abstract).
18. 14C]-methylene dianiline in fed and fasted rats. Toxicologist 36 (226) (Abstract).
19. Kinbara, S., Ishizaki, K., Miyazawa, N., Araki, T., 1993. Protection against alphanaphthylisothiocyanate-induced acute cholestasis in mice by a novel taurine conjugate of ursodeoxycholate (UR-906). Jpn. J. Pharmacol. 63, 125-127.
20. Kopelman, H., Robertson, M.H., Sanders, P.G., Ash, I., 1966. The Epping jaundice. Br. Med. J. 1, 514-516.
21. MacDonald, J.R., Gandolfi, A.J., Sipes, I.G., 1985. Structural requirements for cytoprotective agents in galactosamine-induced hepatic necrosis. Toxicol. Appl. Pharmacol. 81, 17-24.
22. Mashige, F., Imai, K., Osuga, T., 1976. A simple and sensitive assay of total serum bile acids. Clin. Chem. Acta 70, 79-86.
23. McQueen, C.A., Williams, G.M., 1990. Study of the genotoxicity and carcinogenicity of 4,4′-methylene-dianiline and 4,4′-methylene-bis-2-chloroaniline. Mutat. Res. 239, 133-142.
24. Nakashima, T., Taniko, T., Kurlyama, K., 1982. Therapeutic effect of taurine administration on carbon tetrachloride-induced hepatic injury. Jpn. J. Pharmacol. 32, 583-589.
25. Nakashima, T., Kuriyama, K., Takino, T., 1983. Therapeutic and prophylactic effects of taurine administration on experimental liver injury. In: Anonymous Sulfur Amino Acids. Alan R. Liss, New York, 1983, pp. 451-459.
26. Park, F., Quinn, M.R., Wright, C.E., Schuller-Levis, G., 1993. Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells. J. Leukocyte Biol. 54, 119-124.
27. Park, E., Schuller-Levis, G., Quinn, M.R., 1995. Taurine chloramine inhibits production of nitric oxide and TNF-α in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J. Immunol. 154, 4778-4784.
28. Park, E., Schuller-Levis, G., Jia, J-H., Quinn, M.R., 1997. Preactivation exposure of RAW 264.7 cells to taurine chloramine attenuates subsequent production of nitric oxide and expression of iNOS mRNA. J. Leukocyte Biol. 61, 161-167
29. Peterson, J.C., Estiva, E.C., Harris, R.M., 1991. High-performance liquid chromatographic determination of 4-4′-methylenedianiline in human urine. J. Chromatogr. 564, 205-212.
30. Rao, T.K., Dorsey, G.F., Allen, B.E., Epler, J.L., 1982. Mutagenicity of 4,4′-methylenedianiline derivatives in the salmonella histidine reversion assay. Arch. Toxicol. 49, 185-190.
31. Raschke, P., Massoudy, P., Becker, B.F., 1995. Taurine protects teh heart from neutrophilinduced reperfusion injury. Free Radic. Biol. Med. 19, 461-471.
32. Sabbioni, G., Sepai, O., Schultze, D., Miksche, L., Lewalter, J., Henschler, D., 1994. Biomonitoring of workers exposed to 4,4′-methylendianiline (MDA) and 4,4′-methylenediphenyidiisocyanate (MDI). Int. Symp. Human Health Environ., pp. 42 (Abstract).
33. Santa Cruz, V., Wang, A., Kanz, M.F., 1997. Effect of methylenedianiline on tight junction permeability of the biliary tree. Toxicologist 36 (227) (Abstract)
34. Schoental, R., 1968. Pathological lesions including tumors in rats after 4,4'diaminodiphenylmethane and γ-buttyrolactone. Israel J. Med. Sci. 4, 1146-1158.
35. Shaffer, J.E., Kocsis, J.J., 1981. Taurine mobilizing effects of beta alanine and other inhibitors of taurine transport. Life Sci. 28, 2727-2736.
36. Shintani, H., Nakamura, A., 1989. Analysis of a carcinogen, 4,4′-methylenedianiline, from thermosetting polyurethane during sterilization. J. Anal. Toxicol. 13, 354-357.
37. Skarping, G., Dalene, M., 1995. Determination of 4,4′-methylenediphenyidianiline (MDA) and identification of isomers in technical-grade MDA in hydrolysed plasma and urine from workers exposed to methelyne diphenyidiisocyanate by gas chromatography-mass spectrometry. J. Chromatogr. B663, 209-216.
38. Thomas, E.L., Grisham, M.B., Melton, D.F., Jefferson, M.M., 1985. Evidence for a role of taurine in the in vitro oxidative toxicity of neutrophils towards eryithrocytes. J. Biol. Chem. 260, 3321-3329.
39. Tillman, H.L., van Pelt, F.N.A.M., Martz, W., Luescke, T., Welp, H., Dorries, F., Veuskens, A., Fischer, M., Manns, M.P., 1997. Accidental intoxication with methylene dianiline p,p′-diaminodiphenylmethane: Acute liver damage after presumed ecstasy consumption. Clin. Toxicol. 35, 35-40.
40. Timbrell, J.A., Seabra, V., Water-field, C.J., 1995. The in vivo and in vitro protective properties of taurine. Gen. Pharmacol. 26, 453-462.
41. Tsukahara, K., Kanai, S., Ohta, M., Kitani, K., 1993. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats. Liver 13, 262-269.
42. Watanabe, A., Hobara, N., Nagashima, H., 1985. Lowering of liver acetaldehyde but not ethanol concentrations by pretreatment with taurine in ethanol-loaded rats. Experimentia 41, 1421-1422.
43. Waterfield, C.J., Turton, J.A., Scales, M.D.C., Timbrell, J.A., 1991. Taurine, a possible urinary marker of liver damage: a study of taurine excretion in carbon tetrachloride-treated rats. Arch. Toxicol. 65, 548-555.
44. Waterfield, C.J., Turton, J.A., Scales, M.D.C., Timbrell, J.A., 1993a. Investigations into the effects of various hepatotoxic compounds on urinary and liver taurine levels in rats. Arch. Toxicol. 67, 244-254.
45. Waterfield, C.J., Turton, J.A., Scales, M.D.C., Timbrell, J.A., 1993b. Reduction of liver taurine in rats by beta-alanine treatment increases carbon tetrachloride toxicity. Toxicology 77, 7-20.
46. Waterfield, C.J., 1994. Determination of taurine in biological samples and isolated hepatocytes by high-performance liquid chromatography with fluorimetric detection. J. Chromatogr. B 657, 37-45.
47. Yan, C.C., Huxtable, R.J., 1996. Effects of taurine and guanidinorethane sulfonate on toxicity of the pyrrolizidine alkaloid monocrotaline. Biochem. Pharmacol. 51, 321-329.